GSA Capital Partners’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-169,369
| Closed | -$501K | – | 1874 |
|
|
2019
Q1 | $501K | Sell |
169,369
-34,600
| -17% | -$102K | 0.05% | 696 |
|
|
2018
Q4 | $324K | Sell |
203,969
-55,200
| -21% | -$87.7K | 0.04% | 793 |
|
|
2018
Q3 | $954K | Buy |
259,169
+15,800
| +6% | +$58.2K | 0.05% | 713 |
|
|
2018
Q2 | $689K | Buy |
+243,369
| New | +$689K | 0.03% | 974 |
|
|
2018
Q1 | – | Sell |
-133,058
| Closed | -$383K | – | 1939 |
|
|
2017
Q4 | $383K | Sell |
133,058
-183,842
| -58% | -$529K | 0.02% | 1084 |
|
|
2017
Q3 | $1.42M | Sell |
316,900
-70,358
| -18% | -$316K | 0.1% | 307 |
|
|
2017
Q2 | $1.78M | Buy |
387,258
+109,558
| +39% | +$503K | 0.12% | 204 |
|
|
2017
Q1 | $1.17M | Buy |
277,700
+66,673
| +32% | +$281K | 0.06% | 542 |
|
|
2016
Q4 | $872K | Buy |
211,027
+169,679
| +410% | +$701K | 0.05% | 646 |
|
|
2016
Q3 | $335K | Buy |
41,348
+30,050
| +266% | +$243K | 0.02% | 1298 |
|
|
2016
Q2 | $88K | Buy |
+11,298
| New | +$88K | ﹤0.01% | 1679 |
|
|
2015
Q2 | – | Sell |
-12,927
| Closed | -$127K | – | 2287 |
|
|
2015
Q1 | $127K | Buy |
+12,927
| New | +$127K | 0.01% | 1994 |
|